Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000427991 | SCV000533905 | benign | not provided | 2016-11-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001513016 | SCV001720545 | benign | Genitopatellar syndrome | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002494943 | SCV002797937 | likely benign | Genitopatellar syndrome; Blepharophimosis - intellectual disability syndrome, SBBYS type | 2021-09-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000427991 | SCV004033051 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | KAT6B: BP4, BP7, BS1, BS2 |
Breakthrough Genomics, |
RCV000427991 | SCV005315882 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004537695 | SCV004746000 | benign | KAT6B-related disorder | 2019-05-29 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |